Jan 12, 2026 | Acquisition Cost Index (ACI) pricing, Biosimilars, Brand Name Drugs, Drug costs, High-value formulary, MedBen Rx, News, Patient assistance, Pharmacogenomics, Pharmacy
Pharmaceutical manufacturers are planning to raise list prices on at least 350 brand-name medications in the United States beginning in 2026, up from 250 drugs last year, according to new data from health care research firm 3 Axis Advisors. These increases reflect...
Jan 9, 2026 | Flu Shots, Influenza, News, Preventive Care, Vaccinations, Wellness
Earlier this fall, we shared a reminder about the importance of annual flu vaccination and early-season planning. That guidance still holds – but this year’s flu season has raised the stakes. According to the CDC, flu activity has reached its highest level in...
Jan 8, 2026 | Explanation of benefits (EOB), Flexible spending accounts (FSAs), Health flexible spending account (FSA), MedBen Access, Mobile App, Online Services
Going paperless with electronic explanation of benefits (EOBs) is a simple change that makes claims management faster and more convenient. While only about 10% of plan members currently receive electronic EOBs through MedBen Access, those who have made the switch...
Dec 30, 2025 | Benefits preservation, Biosimilars, Client Feedback, Client Surveys, Direct-to-Employer Contracting, Forensic claims review, Innovations, Kurt Harden, MedBen Employees, Self-funding, Spending, Third party administration
On behalf of the MedBen team, I wish you a happy and healthy new year, and thank you for your continued trust in MedBen. Our commitment remains to be the benefits partner that employers prefer, and we value the opportunity to serve you. In my 35 years with MedBen,...
Dec 29, 2025 | MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Rebates, Rx Costs, Transparency
While the major PBMs still dominate the market, their grip is loosening. A recent Pulse of the Purchaser survey found that the percentage of employers contracted with one of the Big 3 dropped from 72% in 2024 to 61% by late 2025, as more organizations shifted toward...
